The circadian clock protein REVERBα inhibits pulmonary fibrosis development

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2019-12-26

DOI: 10.1073/pnas.1912109117

Affiliations: 12

Authors: 24

Go to article
Institutions Share
Faculty of Biology, Medicine and Health (FBMH), UoM, United Kingdom (UK) 0.49
Health Innovation Manchester, United Kingdom (UK) 0.17
Laboratory of Tissue Repair and Regeneration (LTRR), Matrix Dynamics Group, Canada 0.08
UCL Centre for Inflammation and Tissue Repair (CITR), United Kingdom (UK) 0.08
Faculty of Medical Sciences, Newcastle University, United Kingdom (UK) 0.04
MRC Centre for Inflammation Research (CIR), The University of Edinburgh, United Kingdom (UK) 0.04
Chronic Disease Research Centre (CDRC), UWI Barbados, Barbados 0.02
Freeman Hospital, United Kingdom (UK) 0.02
Translational and Clinical Research Institute, Newcastle University, United Kingdom (UK) 0.02
NIHR Oxford Biomedical Research Centre (OxBRC), United Kingdom (UK) 0.02
Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), United Kingdom (UK) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER